Langley Wealth Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Buy
4,489
+22
+0.5% +$1.12K 0.21% 106
2026
Q2
$234K Buy
+4,467
New +$236K 0.23% 108

Other funds holding GSK

Langley Wealth Management's GSK Position: Q3 2026 in Review

Langley Wealth Management increased its GSK (GSK) stake by 0.49% in Q3 2026, buying an estimated $1.12K and bringing the position to 4,489 shares worth $216K. The position accounts for 0.21% of the portfolio, ranked #106.

Langley Wealth Management first reported a position in GSK in Q2 2026 and has held it in 2 quarters since. The position peaked at $234K in Q2 2026. 990 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Langley Wealth Management held 4,489 shares of GSK worth $216K as of Q3 2026.
  • Langley Wealth Management bought 22 GSK shares in Q3 2026, an estimated $1.12K.
  • GSK made up 0.21% of Langley Wealth Management's portfolio in Q3 2026, its #106 holding.
  • Langley Wealth Management first reported a position in GSK in Q2 2026 and has held it in 2 quarters since.
  • Langley Wealth Management's GSK position peaked at $234K in Q2 2026.
  • 990 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Langley Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.